RACHEL MOSKOWITZ: Open Payments
NPI 1437341443 · EAST BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 16 payments from 9 companies in 2025. Trend: 2023 $198 · 2024 $249 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| Insulet Corporation | 2 | $58 |
| Boston Scientific Corporation | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Amphastar Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $30 |
| Indivior Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, Omnipod, WATCHMAN FLX, Cologuard Collection Kit, Ozempic, SUBLOCADE, Rybelsus, LEQVIO.
Industry payments across NJ — which companies pay providers there.
